Qatar sets benchmark in oncology education, hosting first-ever ESMO Advanced Course on Breast Cancer

Doha, Qatar: Hamad Medical Corporation (HMC) continues to play a vital role in enhancing healthcare in Qatar by hosting the ESMO Advanced Course on Br...

Doha, Qatar: Hamad Medical Corporation (HMC) continues to play a vital role in enhancing healthcare in Qatar by hosting the ESMO Advanced Course on Breast Cancer, titled “Filling the Gaps Following Progression on CDK4/6 in Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer”, led by Dr. Salha Bujassoum, Chairperson of Medical Oncology and Palliative Care Medicine.

This milestone event, marking the first of its kind in Qatar, highlighted innovative strategies for managing advanced breast cancer, particularly for patients whose condition progresses after treatment with CDK4/6 inhibitors. With a blend of global expertise and dynamic discussions, the course set Qatar's status as a leader in oncology education.

The course attracted over 100 leading oncologists, researchers, and healthcare professionals from around the globe, all focused on addressing pressing challenges in advanced breast cancer care.

Delegates from Qatar, Saudi Arabia, the Unites Arab Emirates, Italy, France, Austria, Kuwait, Oman, and Spain exchanged ideas and shared best practices. The event featured interactive case discussions that provided practical insights into real-world treatment challenges, expert panels highlighting the latest breakthroughs and clinical innovations, and collaborative networking opportunities, serving as a global platform for fostering partnerships in breast cancer care.